At a glance
ClinicalIndex Comparison RecordN/ACompleted· 69 enrolled
Drug / intervention
Lamotriginedrug
Likely dose
Lamotrigine 25 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Lamotrigine Therapy in the Treatment of Geriatric Bipolar Depression: An Evaluation of Markers of Cerebral Energy Metabolism
In Brief
A clinical study evaluating Lamotrigine for Bipolar Depression. Completed, enrolled 69 participants across 1 site.
Detailed Summary
We propose to study the efficacy and tolerability of lamotrigine in the treatment of older adults with bipolar depression and to compare measures of brain energy metabolism between older subjects with bipolar depression and healthy age-matched controls in order to better understand treatment response in geriatric bipolar depression.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Depression
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2006
First PostedJul 2008
Primary CompletionJul 2011
Study CompletionDec 2011
TodayJul 2026
First PostedJul 22, 2008
Enrollment StartApr 1, 2006
Primary CompletionJul 1, 2011
Study CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 17.9 years ago
Interventions
Lamotriginedrug
Lamotrigine with dosage range from 25 mg to 200 mg per day.